Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe site's revision version was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check18 days agoChange Detected- Revision: v3.4.3 is now active, replacing v3.4.2. This change does not alter the information presented on the page.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.4.2 tag and removed the previous Notice about a lapse in government funding; these are site maintenance/version updates and do not affect the study data or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedNotice added about a lapse in government funding and NIH Clinical Center status, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedThe page adds a glossary display and updates metadata terms (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing the previous QC wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; no substantive content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.